Loteprednol etabonate (5 mg/ml).

Eye suspension

Treatment of post-operative inflammation following ocular surgery.

Posology

Adults and elderly
One to two drops four times daily beginning 24 hours after surgery and continuing throughout the post-operative period.
The duration of treatment should not exceed 2 weeks.

Paediatric Population
Lotemax should not be used in the paediatric age group until further data become available.

Method of administration
Ocular use
Shake the bottle vigorously before using the eye drops.
This product is sterile when packaged. Patients should be advised not to allow the dropper tip to touch any surface, as this may contaminate the suspension. The bottle should be closed immediately after use.